The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
NLS Pharmaceutics
NLSP
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.175200
-0.0012
-0.68%
At Close: -
$0.180000
0.0048
2.74%
After Hours: Aug 23, 7:40 PM EDT
15 minutes delayed
Get Report
Comment
NLS Pharmaceutics (NLSP) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for NLS Pharmaceutics (NASDAQ:NLSP) Stock
NLS Pharmaceutics Stock (NASDAQ: NLSP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 29, 2024
Dow Edges Lower; Ventyx Biosciences Shares Plummet
Avi Kapoor
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
Avi Kapoor
NLS Pharmaceutics shares are trading higher a...
Benzinga Newsdesk
NLS Pharmaceutics And Kadimastem Enter Bindin...
Benzinga Newsdesk
Trading Halt: Halted at 6:56:51 a.m. ET - Tra...
Benzinga Newsdesk
Friday, June 28, 2024
NLS Pharmaceutics shares are trading lower af...
Benzinga Newsdesk
NLS Pharmaceutics Annnounced Registered Direc...
Benzinga Newsdesk
Thursday, June 27, 2024
NLS Pharmaceutics shares are trading higher a...
Benzinga Newsdesk
NLS Pharmaceutics Highlights Preclinical Resu...
Benzinga Newsdesk
Thursday, June 20, 2024
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Dow Edges Lower; US Current Account Deficit Widens In Q1
Avi Kapoor
Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, June 18, 2024
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
US Stocks Mixed; Retail Sales Increase 0.1% In May
Avi Kapoor
Why Chegg Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, June 11, 2024
NLS Pharmaceutics Announces Publication Of Ne...
Benzinga Newsdesk
Tuesday, May 28, 2024
NLS Pharmaceutics Reports Results From Study ...
Benzinga Newsdesk
Wednesday, March 20, 2024
NLS Pharmaceutics Announces $1.75M Registered...
Benzinga Newsdesk
NLS Pharmaceutics shares are trading higher a...
Benzinga Newsdesk
NLS Pharmaceutics Secures Exclusive Global Li...
Benzinga Newsdesk
Monday, March 11, 2024
NLS Pharmaceutics Has Been Notified By The Li...
Benzinga Newsdesk
Friday, February 23, 2024
NLS Pharmaceutics Says It Submited Plan To Re...
Benzinga Newsdesk
Friday, January 12, 2024
NLS Pharmaceutics Announced Nasdaq Letter Rel...
Benzinga Newsdesk
Monday, December 04, 2023
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Friday, December 01, 2023
NLS Pharmaceutics Launches Exclusive Option A...
Benzinga Newsdesk
Thursday, November 16, 2023
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Why NLS Pharmaceutics (NLSP) Stock Is Down 40% Today
Henry Khederian
NLS Pharmaceutics Announces Selection Of Stra...
Benzinga Newsdesk
Monday, November 13, 2023
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Wednesday, October 25, 2023
NLS Pharmaceutics Announces Receipt of Nasdaq...
Benzinga Newsdesk
Thursday, October 12, 2023
NLS Pharmaceutics Announces Company Update On...
Benzinga Newsdesk
Monday, October 02, 2023
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Thursday, September 14, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2023
Benzinga Insights
Maxim Group Downgrades NLS Pharmaceutics to H...
Benzinga Newsdesk
Thursday, August 31, 2023
Why Okta Shares Are Trading Higher By 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Monday, August 28, 2023
NLS Pharmaceutics CEO Highlights Progress And Plans For Advancing Rare CNS Disorder Therapies In Shareholder Letter
Kenneth Adams
-
Sponsored
NLS Pharmaceutics Says Received Several Non-B...
Benzinga Newsdesk
Wednesday, July 26, 2023
Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
Friday, July 07, 2023
Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
Monday, July 03, 2023
NLS Pharmaceutics shares are trading higher a...
Benzinga Newsdesk
NLS Pharmaceutics To Proceed With Phase 3 Cli...
Bill Haddad
Wednesday, June 14, 2023
NLS Pharmaceutics Announces Safety Data From ...
Benzinga Newsdesk
Tuesday, May 02, 2023
NLS Pharmaceutics Receives Green Light from T...
Benzinga Newsdesk
Monday, March 27, 2023
NLS Pharmaceutics Announces Open Label Extens...
Benzinga Newsdesk
Monday, January 30, 2023
NLS Pharmaceutics Announces Completion Of Ope...
Benzinga Newsdesk
Wednesday, January 25, 2023
NLS Pharmaceutics Regains Compliance With Nas...
Bill Haddad
Monday, January 23, 2023
NLS Pharmaceutics Announces New In-Vitro Data On Quilience's Dual Mechanism Of Action Involving Orexin-2 Receptor Activity
Bill Haddad
Tuesday, January 17, 2023
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Show More